Published by Coherent Market Insights
Posted on October 4, 2021
The growing prevalence of blood-related disorders is fostering the growth of the blood transfusion devices market. As per estimates by the NIH and National Heart, Lung, and Blood Institute, blood transfusions are very common in the U.S., as each year, over 5 million Americans need blood transfusions, which increases the demand for blood transfusion devices. Increasing healthcare expenditure across developing regions is again propelling the growth of the blood transfusion devices market. According to the U.S. Centers for Medicare & Medicaid Services, National health spending is projected to grow at an average annual rate of 5.4 percent for 2019-28 and to reach $6.2 trillion by 2028.
Request For Sample Copy of This Premium Research Blood Transfusion Devices Market @
https://www.coherentmarketinsights.com/insight/request-sample/4156
North America is expected to hold the dominant position in the global blood transfusion devices market and this is attributed to the increasing demand for blood transfusion in the U.S. For instance, according to the American National Red Cross, approximately 36,000 units of red blood cells are needed every day and around 21 million blood components are transfused each year in the U.S.
The human blood Transfusion Device market is expected to be largely driven by an increase in the number of acute kidney infections and a rise in the occurrence of multiple blood-borne diseases around the world. Moreover, recent technological developments in micro-fabricated infusion pumps, automated apheresis machines, blood collection and warming systems, and infusion pumps have facilitated the accessibility of highly purified and safe components for performing blood transfusions. Despite this, blood-borne pathogens continue to pose a significant risk for public health. This highlights the urgent need for developing new approaches and technologies for addressing this critical issue.
Key Developments:
In April 2021, EryPharm launched a medical device product to mass-produce cultured red blood cells and develop new sourcing for blood transfusions. The product will improve the quality of life of multi-transfused patients who suffer from hereditary or acquired diseases of the red blood cells in particular,
In April 2019, Illinois-based Ecomed Solutions launched HEMAsavR, a blood management device that can be installed in operating theatres to collect a patient’s lost blood during surgery and return it to their body.
Major Players in Blood Transfusion Devices Market
Fresenius Kabi AG, Grifols, S.A., Tenko International Group Corp, Terumo Corporation, Kawasumi Laboratories, Inc., Haemonetics Corporation, Bioelectronica MILANO, RAYS S.P.A., Macopharma SA, B. Braun Melsungen AG, Baxter International Inc., Neomedic Limited, and 3M Company.
Ask for PDF sample copy of the Blood Transfusion Devices market report @
https://www.coherentmarketinsights.com/insight/request-pdf/4156
Blood Transfusion Devices Market insights will improve the revenue impact of businesses in various industries:
• providing a framework tailored toward understanding the attractiveness quotient of various products/solutions/technologies in the Blood Transfusion Devices Market
• Guiding stakeholders to identify key problem areas pertaining to their consolidation strategies in the global Blood Transfusion Devices market and offers solutions
• assessing the impact of changing regulatory dynamics in the regions in which companies are keen on expanding their footprints
• provides an understanding of disruptive technology trends to help businesses make their transitions smoothly
• helping leading companies make strategy recalibrations ahead of their competitors and peers
• Offers insights into promising growth for top players aiming to retain their leadership position in the market & supply-side analysis of the Blood Transfusion Devices market.
Reasons to Purchase this Report
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/4156
In conclusion, the Blood Transfusion Devices market report presents the descriptive analysis of the parent market supported elite players, present, past, and artistic movement information which is in a position to function as a profitable guide for all the Blood Transfusion Devices industry business competitors. Our expert research analyst’s team has been trained to supply in-depth marketing research reports from every individual sector which can be helpful to know the industry data within the most precise way.
Contact:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post Blood Transfusion Devices Market – Increasing Launches of Blood Transfusion Devices by manufacturers is expected to boost the growth of the market appeared first on Gatorledger.
The growing prevalence of blood-related disorders is fostering the growth of the blood transfusion devices market. As per estimates by the NIH and National Heart, Lung, and Blood Institute, blood transfusions are very common in the U.S., as each year, over 5 million Americans need blood transfusions, which increases the demand for blood transfusion devices. Increasing healthcare expenditure across developing regions is again propelling the growth of the blood transfusion devices market. According to the U.S. Centers for Medicare & Medicaid Services, National health spending is projected to grow at an average annual rate of 5.4 percent for 2019-28 and to reach $6.2 trillion by 2028.
Request For Sample Copy of This Premium Research Blood Transfusion Devices Market @
https://www.coherentmarketinsights.com/insight/request-sample/4156
North America is expected to hold the dominant position in the global blood transfusion devices market and this is attributed to the increasing demand for blood transfusion in the U.S. For instance, according to the American National Red Cross, approximately 36,000 units of red blood cells are needed every day and around 21 million blood components are transfused each year in the U.S.
The human blood Transfusion Device market is expected to be largely driven by an increase in the number of acute kidney infections and a rise in the occurrence of multiple blood-borne diseases around the world. Moreover, recent technological developments in micro-fabricated infusion pumps, automated apheresis machines, blood collection and warming systems, and infusion pumps have facilitated the accessibility of highly purified and safe components for performing blood transfusions. Despite this, blood-borne pathogens continue to pose a significant risk for public health. This highlights the urgent need for developing new approaches and technologies for addressing this critical issue.
Key Developments:
In April 2021, EryPharm launched a medical device product to mass-produce cultured red blood cells and develop new sourcing for blood transfusions. The product will improve the quality of life of multi-transfused patients who suffer from hereditary or acquired diseases of the red blood cells in particular,
In April 2019, Illinois-based Ecomed Solutions launched HEMAsavR, a blood management device that can be installed in operating theatres to collect a patient’s lost blood during surgery and return it to their body.
Major Players in Blood Transfusion Devices Market
Fresenius Kabi AG, Grifols, S.A., Tenko International Group Corp, Terumo Corporation, Kawasumi Laboratories, Inc., Haemonetics Corporation, Bioelectronica MILANO, RAYS S.P.A., Macopharma SA, B. Braun Melsungen AG, Baxter International Inc., Neomedic Limited, and 3M Company.
Ask for PDF sample copy of the Blood Transfusion Devices market report @
https://www.coherentmarketinsights.com/insight/request-pdf/4156
Blood Transfusion Devices Market insights will improve the revenue impact of businesses in various industries:
• providing a framework tailored toward understanding the attractiveness quotient of various products/solutions/technologies in the Blood Transfusion Devices Market
• Guiding stakeholders to identify key problem areas pertaining to their consolidation strategies in the global Blood Transfusion Devices market and offers solutions
• assessing the impact of changing regulatory dynamics in the regions in which companies are keen on expanding their footprints
• provides an understanding of disruptive technology trends to help businesses make their transitions smoothly
• helping leading companies make strategy recalibrations ahead of their competitors and peers
• Offers insights into promising growth for top players aiming to retain their leadership position in the market & supply-side analysis of the Blood Transfusion Devices market.
Reasons to Purchase this Report
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/4156
In conclusion, the Blood Transfusion Devices market report presents the descriptive analysis of the parent market supported elite players, present, past, and artistic movement information which is in a position to function as a profitable guide for all the Blood Transfusion Devices industry business competitors. Our expert research analyst’s team has been trained to supply in-depth marketing research reports from every individual sector which can be helpful to know the industry data within the most precise way.
Contact:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post Blood Transfusion Devices Market – Increasing Launches of Blood Transfusion Devices by manufacturers is expected to boost the growth of the market appeared first on Gatorledger.
Explore more articles in the Research Reports category
